Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: May 28, 2022

CLINICAL TRIALS PROFILE FOR ANAGRELIDE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Anagrelide Hydrochloride

Subscribe to access the full database, or Sign up for a Free Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00175838 ↗	Primary Thrombocythaemia 1 Trial	Completed	Cambridge University Hospitals NHS Foundation Trust	N/A	1997-07-01	The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
NCT00175838 ↗	Primary Thrombocythaemia 1 Trial	Completed	Institute of Cancer Research, United Kingdom	N/A	1997-07-01	The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
NCT00175838 ↗	Primary Thrombocythaemia 1 Trial	Completed	University of Cambridge	N/A	1997-07-01	The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Anagrelide Hydrochloride

Condition Name

Chart
Table

Condition Name for Anagrelide Hydrochloride
Intervention	Trials
Essential Thrombocythemia	6
Essential Thrombocythaemia	4
Essential Thrombocythemia (ET)	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Anagrelide Hydrochloride
Intervention	Trials
Thrombocytosis	17
Thrombocythemia, Essential	17
Polycythemia Vera	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Anagrelide Hydrochloride

Trials by Country

Map
Table

Trials by Country for Anagrelide Hydrochloride
Location	Trials
United States	92
Japan	37
China	14
Germany	14
Canada	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Anagrelide Hydrochloride
Location	Trials
New York	6
California	6
Arizona	6
North Carolina	5
Texas	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Anagrelide Hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Anagrelide Hydrochloride
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	8
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Anagrelide Hydrochloride
Clinical Trial Phase	Trials
Completed	18
Recruiting	2
Terminated	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Anagrelide Hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for Anagrelide Hydrochloride
Sponsor	Trials
Shire	6
AOP Orphan Pharmaceuticals AG	3
Novartis Pharmaceuticals	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Anagrelide Hydrochloride
Sponsor	Trials
Industry	26
Other	15
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

AstraZeneca

Baxter

Harvard Business School

Boehringer Ingelheim

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.